Skip to main content

HRS 2023

Clinical Highlights

POLARx™/POLARx™ FIT Cryoablation System

#HRS2023: POLARx™ FIT Expandable Cryoballoon

Watch Dr. Ken Ellenbogen, Hermes A. Kontos Professorship and Director of Cardiac Electrophysiology and Pacing at VCU Health and Dr. Kevin Makati, president of Tampa Cardiac Specialists, co-director of the electrophysiology department at BayCare Health System and Assistant Professor at USF Department of Internal Medicine discuss their experience with the POLARx FIT expandable cryoballoon and the recently presented FROzEN-AF US IDE clinical trial data.

Ellenbogen, et al. (2023) One-year outcomes of pulmonary vein isolation with a novel cryoballoon in 325 patients: Primary results of the FROzEN-AF trial.

FARAPULSE™ Pulsed Field Ablation System*

Turagam et al. (2023) Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: One-year outcomes from the MANIFEST-PF registry.

Schmidt, et al. (2023) European real-world outcomes with pulsed field ablation in patients with symptomatic atrial fibrillation - Lessons from the multicenter EU-PORIA registry.

POLARx and POLARx FIT Cryoablation System Indications, Safety and Warnings


*CAUTION: Investigational Device. Limited by Federal (or US) law to investigational use only. Not available for sale.